MICROSOFT HAS told The INQUIRER that it is aware of a bug which has been causing users' default programs to switch to the bundled Microsoft options. The saga began when a reader told us that, despite being a long …
Microsoft
According to sources close to the situation, Microsoft CEO Steve Ballmer is working on what is likely to turn into a significant restructuring of the massive software company, which could also move several current execs to …
Investors appear to be quite pleased with the today’s big news that Microsoft CEO Steve Ballmer will step down in the next 12 months, pushing Microsoft’s stock up about 8 percent this morning. “This is an emotional and …
Microsoft
When Microsoft produced a video about its history, they of course mentioned the 1986 public stock offering: The video also describes Fortune's 1986 story about Bill Gates and his stock. The article was recently posted …
Bill Gates
Microsoft's focus on business software and online services paid off with a surprisingly high profit in its latest quarter, putting its stock on a trajectory toward its all-time high. The fiscal first-quarter results released …
Microsoft’s former head of Windows 8 development has agreed not to badmouth Microsoft or work for some of its competitors and in return will receive a payout for unvested stock in the company, according to a regulatory …
A skeptical take from Jefferies & Co.is weighing on Microsoft shares Friday, but the bear case for the stock isn’t so obvious. Late Thursday analyst John DiFucci initiated coverage of Microsoft (ticker: MSFT) with an …
Goldman Sachs has published a 22-page research note looking at Microsoft's business and its opportunities. The research, titled "Righting a Wrong," upgrades Microsoft stock from a Sell rating to Neutral. The research note …
Microsoft
Microsoft (MSFT) was once the king of the computing world. When the company released a new operating system its stock would typically flourish in the years following the launch. Times have changed, however, and …
BGR4y
Adamas Pharmaceuticals (ADMS) is a drug improvement company that develops chrono-synchronous therapies for patients affected by chronic …